Literature DB >> 23195935

Placebo-controlled, randomized double-blind clinical trial with Sinupret® sugar coated tablets on the basis of a therapy with antibiotics and decongestant nasal drops in acute sinusitis.

N Neubauer1, R W März.   

Abstract

On the basis of therapy with antibiotics and nasal decongestants the efficacy of an additional treatment with the herbal combination Sinupret containing gentian root, cowslip flowers, sour dock herbs, elder flowers and shop vervain wort herbs was assessed in a randomized, placebo-controlled double-blind clinical trial involving 160 patients with acute bacterial sinusitis. Primary outcome criteria were radiographic findings and patient assessment. Secondary variables were several clinical symptoms of sinusitis which served as indicators of the pharmacological profile. The results showed that, according to the radiographic findings and the patient assessments, therapy with antibiotic and decongestants achieved a significant improvement in the treatment group; changes in clinical signs showed good correlation with the radiographic findings and the patient assessments. Conventional therapy for acute bacterial sinusitis can be improved markedly by including Sinupret in the therapeutic regimen.
Copyright © 1994 Gustav Fischer Verlag, Stuttgart · Jena · New York. Published by Elsevier GmbH.. All rights reserved.

Entities:  

Year:  1994        PMID: 23195935     DOI: 10.1016/S0944-7113(11)80061-9

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  9 in total

1.  [Rhinosinusitis guidelines--unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; R Weber; K Hörmann
Journal:  HNO       Date:  2012-02       Impact factor: 1.284

2.  The value of herbal medicines in the treatment of acute non-purulent rhinosinusitis. Results of a double-blind, randomised, controlled trial.

Authors:  Stefan Tesche; Frank Metternich; Uwe Sonnemann; Jan-Christian Engelke; Uwe Dethlefsen
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-04-25       Impact factor: 2.503

3.  [Rhinosinusitis guidelines of the German Society for Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; K Hörmann
Journal:  HNO       Date:  2007-10       Impact factor: 1.284

4.  [Guideline for "rhinosinusitis"-long version : S2k guideline of the German College of General Practitioners and Family Physicians and the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery].

Authors:  B A Stuck; A Beule; D Jobst; L Klimek; M Laudien; M Lell; T J Vogl; U Popert
Journal:  HNO       Date:  2018-01       Impact factor: 1.284

5.  [Homeopathy in acute rhinosinusitis: a double-blind, placebo controlled study shows the efficiency and tolerability of a homeopathic combination remedy].

Authors:  K-H Friese; D I Zabalotnyi
Journal:  HNO       Date:  2007-04       Impact factor: 1.284

Review 6.  Phytoneering: a new way of therapy for rhinosinusitis.

Authors:  D Passali; J Cambi; F M Passali; L M Bellussi
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-02       Impact factor: 2.124

Review 7.  The role of bitter and sweet taste receptors in upper airway innate immunity: Recent advances and future directions.

Authors:  Ivy W Maina; Alan D Workman; Noam A Cohen
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2018-08-24

Review 8.  Common Cold and Acute Rhinosinusitis: Up-to-Date Management in 2020.

Authors:  Francesca Jaume; Meritxell Valls-Mateus; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2020-06-03       Impact factor: 4.806

Review 9.  Complementary and integrative treatments: rhinosinusitis.

Authors:  Malcolm B Taw; Chau T Nguyen; Marilene B Wang
Journal:  Otolaryngol Clin North Am       Date:  2013-04-28       Impact factor: 3.346

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.